Seagen/Genmab's Tivdak Set To Take On Merck’s Keytruda

 
• By Joseph Haas
  
Businessman Success. A businessman launching upwards, paperwork flying everywhere!
Seagen gets its fourth FDA approval and third ADC with Tivdak okay
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip